Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06582719 · ClinicalTrials.gov registry record · NA

Evaluating the Efficacy of GPT-based Nutrition and Diabetic Counseling in Gestational Diabetes Management: A Randomized Controlled Trial (AIM-GDM)

A NA study of Gestational Diabetes, sponsored by Montefiore Medical Center.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT06582719 is a NA study of Gestational Diabetes that is actively recruiting participants, run by Montefiore Medical Center. The registered enrollment target is 80 participants, below the 320-participant average among 41 other Gestational Diabetes trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06582719, a NA study of Gestational Diabetes, is actively recruiting participants, sponsored by Montefiore Medical Center.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess whether an AI based counseling service can be beneficial for patients to assist in management of gestational diabetes.

Conditions Studied

Interventions

  • DEVICE GPT-based counseling
  • OTHER Nutritional Counseling

Study Locations (1)

New York

  • Montefiore Medical Center - The Bronx

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2025-05-29
Est. Completion 2027-01
Phase NA

Sponsor

Montefiore Medical Center

345 total trials

What the Registry Record Tells You About NCT06582719

The ClinicalTrials.gov registry entry for NCT06582719 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 320-participant average among 41 other Gestational Diabetes trials with a reported enrollment target (75% lower). The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gestational Diabetes appearing as the primary indexed condition, and to 2 interventions - of which GPT-based counseling is the first listed.

NCT06582719 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06582719 about?

NCT06582719 is a clinical study titled "Evaluating the Efficacy of GPT-based Nutrition and Diabetic Counseling in Gestational Diabetes Management: A Randomized Controlled Trial (AIM-GDM)". The purpose of this study is to assess whether an AI based counseling service can be beneficial for patients to assist in management of gestational diabetes.

What is the current status of trial NCT06582719?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-05-29. Estimated completion is 2027-01.

What conditions does trial NCT06582719 study?

This clinical trial studies the following conditions: Gestational Diabetes.

What interventions are being tested in trial NCT06582719?

The interventions under investigation include: GPT-based counseling (DEVICE), Nutritional Counseling (OTHER).

Who is sponsoring clinical trial NCT06582719?

This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06582719 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gestational Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.